{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:36:11Z","timestamp":1787884571013,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL141366"],"award-info":[{"award-number":["R01 HL141366"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK088327"],"award-info":[{"award-number":["R01 DK088327"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52869-3","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:02:03Z","timestamp":1728043323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Platelet integrin \u03b1IIb\u03b23 plays a key role in a venous thrombogenesis mouse model"],"prefix":"10.1038","volume":"15","author":[{"given":"Brian D.","family":"Adair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conroy O.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Xian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivgeni","family":"Mashin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9245","authenticated-orcid":false,"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"van Agthoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-9603","authenticated-orcid":false,"given":"Youzhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Tess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortimer","family":"Poncz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-0371","authenticated-orcid":false,"given":"M. Amin","family":"Arnaout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"52869_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","volume":"12","author":"JA Heit","year":"2015","unstructured":"Heit, J. A. Epidemiology of venous thromboembolism. Nat. Rev. Cardiol. 12, 464\u2013474 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"52869_CR2","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1055\/s-0040-1718532","volume":"120","author":"S Schulman","year":"2020","unstructured":"Schulman, S., Hu, Y. & Konstantinides, S. Venous thromboembolism in COVID-19. Thromb. Haemost. 120, 1642\u20131653 (2020).","journal-title":"Thromb. Haemost."},{"key":"52869_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","volume":"398","author":"F Khan","year":"2021","unstructured":"Khan, F., Tritschler, T., Kahn, S. R. & Rodger, M. A. Venous thromboembolism. Lancet 398, 64\u201377 (2021).","journal-title":"Lancet"},{"key":"52869_CR4","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa022157","volume":"348","author":"P Prandoni","year":"2003","unstructured":"Prandoni, P. et al. An association between atherosclerosis and venous thrombosis. N. Engl. J. Med. 348, 1435\u20131441 (2003).","journal-title":"N. Engl. J. Med."},{"key":"52869_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.6","volume":"1","author":"AS Wolberg","year":"2015","unstructured":"Wolberg, A. S. et al. Venous thrombosis. Nat. Rev. Dis. Prim. 1, 15006 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"52869_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/jcp.27.7.517","volume":"27","author":"S Sevitt","year":"1974","unstructured":"Sevitt, S. The structure and growth of valve-pocket thrombi in femoral veins. J. Clin. Pathol. 27, 517\u2013528 (1974).","journal-title":"J. Clin. Pathol."},{"key":"52869_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Bruhl","year":"2012","unstructured":"von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819\u2013835 (2012).","journal-title":"J. Exp. Med."},{"key":"52869_CR8","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","volume":"366","author":"C Becattini","year":"2012","unstructured":"Becattini, C. et al. Aspirin for preventing the recurrence of venous thromboembolism. N. Engl. J. Med. 366, 1959\u20131967 (2012).","journal-title":"N. Engl. J. Med."},{"key":"52869_CR9","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","volume":"367","author":"TA Brighton","year":"2012","unstructured":"Brighton, T. A. et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N. Engl. J. Med. 367, 1979\u20131987 (2012).","journal-title":"N. Engl. J. Med."},{"key":"52869_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","volume":"130","author":"J Simes","year":"2014","unstructured":"Simes, J. et al. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 130, 1062\u20131071 (2014).","journal-title":"Circulation"},{"key":"52869_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.117.031062","volume":"137","author":"I Cavallari","year":"2018","unstructured":"Cavallari, I. et al. Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis. Circulation 137, 684\u2013692 (2018).","journal-title":"Circulation"},{"key":"52869_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-2003-40670","volume":"3","author":"AT Nurden","year":"2003","unstructured":"Nurden, A. T. & Nurden, P. GPIIb\/IIIa antagonists and other anti-integrins. Semin Vasc. Med. 3, 123\u2013130 (2003).","journal-title":"Semin Vasc. Med."},{"key":"52869_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrd.2015.10","volume":"15","author":"K Ley","year":"2016","unstructured":"Ley, K., Rivera-Nieves, J., Sandborn, W. J. & Shattil, S. Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat. Rev. Drug Discov. 15, 173\u2013183 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52869_CR14","doi-asserted-by":"publisher","first-page":"11947","DOI":"10.1074\/jbc.270.20.11947","volume":"270","author":"S Honda","year":"1995","unstructured":"Honda, S. et al. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit. J. Biol. Chem. 270, 11947\u201311954 (1995).","journal-title":"J. Biol. Chem."},{"key":"52869_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nsmb.2797","volume":"21","author":"JF Van Agthoven","year":"2014","unstructured":"Van Agthoven, J. F. et al. Structural basis for pure antagonism of integrin alphaVbeta3 by a high-affinity form of fibronectin. Nat. Struct. Mol. Biol. 21, 383\u2013388 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"52869_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13928-2","volume":"11","author":"BD Adair","year":"2020","unstructured":"Adair, B. D. et al. Structure-guided design of pure orthosteric inhibitors of alphaIIbbeta3 that prevent thrombosis but preserve hemostasis. Nat. Commun. 11, 398 (2020).","journal-title":"Nat. Commun."},{"key":"52869_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.bpj.2016.01.016","volume":"110","author":"XP Xu","year":"2016","unstructured":"Xu, X. P. et al. Three-dimensional structures of full-length, membrane-embedded human alpha(IIb)beta(3) integrin complexes. Biophys. J. 110, 798\u2013809 (2016).","journal-title":"Biophys. J."},{"key":"52869_CR18","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1182\/blood-2013-04-499194","volume":"122","author":"WS Choi","year":"2013","unstructured":"Choi, W. S., Rice, W. J., Stokes, D. L. & Coller, B. S. Three-dimensional reconstruction of intact human integrin alphaIIbbeta3: new implications for activation-dependent ligand binding. Blood 122, 4165\u20134171 (2013).","journal-title":"Blood"},{"key":"52869_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2023.184143","volume":"1865","author":"P Dhankhar","year":"2023","unstructured":"Dhankhar, P., Trinh, T. K. H., Qiu, W. & Guo, Y. Characterization of Ca(2+)-ATPase, LMCA1, with native cell membrane nanoparticles system. Biochim. Biophys. Acta Biomembr. 1865, 184143 (2023).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"52869_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39763-0","volume":"14","author":"BD Adair","year":"2023","unstructured":"Adair, B. D., Xiong, J. P., Yeager, M. & Arnaout, M. A. Cryo-EM structures of full-length integrin alphaIIbbeta3 in native lipids. Nat. Commun. 14, 4168 (2023).","journal-title":"Nat. Commun."},{"key":"52869_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.6026\/97320630009432","volume":"9","author":"V Sivasakthi","year":"2013","unstructured":"Sivasakthi, V. et al. Aromatic-aromatic interactions: analysis of pi-pi interactions in interleukins and TNF proteins. Bioinformation 9, 432\u2013439 (2013).","journal-title":"Bioinformation"},{"key":"52869_CR22","doi-asserted-by":"publisher","first-page":"9459","DOI":"10.1073\/pnas.96.17.9459","volume":"96","author":"JP Gallivan","year":"1999","unstructured":"Gallivan, J. P. & Dougherty, D. A. Cation-pi interactions in structural biology. Proc. Natl Acad. Sci. USA 96, 9459\u20139464 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"52869_CR23","first-page":"34","volume":"133","author":"MA Arnaout","year":"2023","unstructured":"Arnaout, M. A. Integrins: a bedside to bench to bedside story. Trans. Am. Clin. Climatol. Assoc. 133, 34\u201355 (2023).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"52869_CR24","doi-asserted-by":"publisher","unstructured":"Cody, V. et al. Structural Analysis of the Complex of Human Transthyretin with 3\u2019,5\u2019-Dichlorophenylanthranilic Acid at 1.5 A Resolution. Molecules 27, https:\/\/doi.org\/10.3390\/molecules27217206 (2022).","DOI":"10.3390\/molecules27217206"},{"key":"52869_CR25","first-page":"1360","volume":"27","author":"S Vickers","year":"1999","unstructured":"Vickers, S. et al. In vitro and in vivo studies on the metabolism of tirofiban. Drug Metab. Dispos. 27, 1360\u20131366 (1999).","journal-title":"Drug Metab. Dispos."},{"key":"52869_CR26","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.CIR.88.4.1512","volume":"88","author":"K Peerlinck","year":"1993","unstructured":"Peerlinck, K. et al. MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb\/IIIa antagonist, is active in man. Circulation 88, 1512\u20131517 (1993).","journal-title":"Circulation"},{"key":"52869_CR27","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1021\/bi1009858","volume":"49","author":"RR Hantgan","year":"2010","unstructured":"Hantgan, R. R., Stahle, M. C. & Lord, S. T. Dynamic regulation of fibrinogen: integrin alphaIIbbeta3 binding. Biochemistry 49, 9217\u20139225 (2010).","journal-title":"Biochemistry"},{"key":"52869_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/01.CIR.100.4.437","volume":"100","author":"RM Scarborough","year":"1999","unstructured":"Scarborough, R. M., Kleiman, N. S. & Phillips, D. R. Platelet glycoprotein IIb-IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? Circulation 100, 437\u2013444 (1999).","journal-title":"Circulation"},{"key":"52869_CR29","first-page":"1277","volume":"286","author":"SA Mousa","year":"1998","unstructured":"Mousa, S. A. et al. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb\/IIIa antagonist: comparative platelet binding profiles with c7E3. J. Pharm. Exp. Ther. 286, 1277\u20131284 (1998).","journal-title":"J. Pharm. Exp. Ther."},{"key":"52869_CR30","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1074\/jbc.M115.706861","volume":"291","author":"RI Litvinov","year":"2016","unstructured":"Litvinov, R. I., Farrell, D. H., Weisel, J. W. & Bennett, J. S. The platelet integrin alphaIIbbeta3 differentially interacts with fibrin versus fibrinogen. J. Biol. Chem. 291, 7858\u20137867 (2016).","journal-title":"J. Biol. Chem."},{"key":"52869_CR31","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1172\/JCI124791","volume":"129","author":"JD Welsh","year":"2019","unstructured":"Welsh, J. D. et al. Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis. J. Clin. Investig. 129, 5489\u20135500 (2019).","journal-title":"J. Clin. Investig."},{"key":"52869_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/TA.0000000000003945","volume":"95","author":"MH Hoofnagle","year":"2023","unstructured":"Hoofnagle, M. H. et al. Defects in vein valve PROX1\/FOXC2 antithrombotic pathway in endothelial cells drive the hypercoagulable state induced by trauma and critical illness. J. Trauma Acute Care Surg. 95, 197\u2013204 (2023).","journal-title":"J. Trauma Acute Care Surg."},{"key":"52869_CR33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jth.14413","volume":"17","author":"JA Diaz","year":"2019","unstructured":"Diaz, J. A. et al. Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application. J. Thromb. Haemost. 17, 699\u2013707 (2019).","journal-title":"J. Thromb. Haemost."},{"key":"52869_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1182\/blood-2015-05-647560","volume":"127","author":"V Tutwiler","year":"2016","unstructured":"Tutwiler, V. et al. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. Blood 127, 149\u2013159 (2016).","journal-title":"Blood"},{"key":"52869_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bpj.2017.01.005","volume":"112","author":"V Tutwiler","year":"2017","unstructured":"Tutwiler, V., Wang, H., Litvinov, R. I., Weisel, J. W. & Shenoy, V. B. Interplay of platelet contractility and elasticity of fibrin\/erythrocytes in blood clot retraction. Biophys. J. 112, 714\u2013723 (2017).","journal-title":"Biophys. J."},{"key":"52869_CR36","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1182\/blood-2007-03-080184","volume":"110","author":"C Leon","year":"2007","unstructured":"Leon, C. et al. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 110, 3183\u20133191 (2007).","journal-title":"Blood"},{"key":"52869_CR37","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1182\/blood.V73.7.1880.1880","volume":"73","author":"I Cohen","year":"1989","unstructured":"Cohen, I., Burk, D. L. & White, J. G. The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension. Blood 73, 1880\u20131887 (1989).","journal-title":"Blood"},{"key":"52869_CR38","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.1074\/jbc.M008945200","volume":"276","author":"S Osdoit","year":"2001","unstructured":"Osdoit, S. & Rosa, J. P. Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation. J. Biol. Chem. 276, 6703\u20136710 (2001).","journal-title":"J. Biol. Chem."},{"key":"52869_CR39","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1016\/j.cell.2022.08.008","volume":"185","author":"FY Lin","year":"2022","unstructured":"Lin, F. Y. et al. A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell 185, 3533\u20133550.e3527 (2022).","journal-title":"Cell"},{"key":"52869_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1067\/mcp.2002.121829","volume":"71","author":"LZ Benet","year":"2002","unstructured":"Benet, L. Z. & Hoener, B. A. Changes in plasma protein binding have little clinical relevance. Clin. Pharm. Ther. 71, 115\u2013121 (2002).","journal-title":"Clin. Pharm. Ther."},{"key":"52869_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrd3287","volume":"9","author":"DA Smith","year":"2010","unstructured":"Smith, D. A., Di, L. & Kerns, E. H. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat. Rev. Drug Discov. 9, 929\u2013939 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52869_CR42","doi-asserted-by":"publisher","first-page":"8238","DOI":"10.1021\/jm5007935","volume":"57","author":"X Liu","year":"2014","unstructured":"Liu, X., Wright, M. & Hop, C. E. Rational use of plasma protein and tissue binding data in drug design. J. Med. Chem. 57, 8238\u20138248 (2014).","journal-title":"J. Med. Chem."},{"key":"52869_CR43","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1080\/17460441.2021.1961741","volume":"16","author":"L Di","year":"2021","unstructured":"Di, L. An update on the importance of plasma protein binding in drug discovery and development. Expert Opin. Drug Discov. 16, 1453\u20131465 (2021).","journal-title":"Expert Opin. Drug Discov."},{"key":"52869_CR44","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1021\/acs.analchem.2c04864","volume":"95","author":"Z Yan","year":"2023","unstructured":"Yan, Z. et al. New methodology for determining plasma protein binding kinetics using an enzyme reporter assay coupling with high-resolution mass spectrometry. Anal. Chem. 95, 4086\u20134094 (2023).","journal-title":"Anal. Chem."},{"key":"52869_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.RES.0000232317.84122.0c","volume":"99","author":"M Schwarz","year":"2006","unstructured":"Schwarz, M. et al. Conformation-specific blockade of the integrin GPIIb\/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ. Res. 99, 25\u201333 (2006).","journal-title":"Circ. Res."},{"key":"52869_CR46","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/MCA.0000000000000126","volume":"25","author":"G Ndrepepa","year":"2014","unstructured":"Ndrepepa, G. et al. Correlates of poor outcome among patients with bleeding after coronary interventions. Coron. Artery Dis. 25, 456\u2013462 (2014).","journal-title":"Coron. Artery Dis."},{"key":"52869_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1527-3466.2001.tb00181.x","volume":"19","author":"K Baba","year":"2001","unstructured":"Baba, K., Aga, Y., Nakanishi, T., Motoyama, T. & Ueno, H. UR-3216: a manageable oral GPIIb\/IIIa antagonist. Cardiovasc. drug Rev. 19, 25\u201340 (2001).","journal-title":"Cardiovasc. drug Rev."},{"key":"52869_CR48","doi-asserted-by":"publisher","unstructured":"Michel, M. C., Michel-Reher, M. B. & Hein, P. A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes. Cells 9, https:\/\/doi.org\/10.3390\/cells9091923 (2020).","DOI":"10.3390\/cells9091923"},{"key":"52869_CR49","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/mp.2012.145","volume":"18","author":"FJ Meye","year":"2013","unstructured":"Meye, F. J., Trezza, V., Vanderschuren, L. J., Ramakers, G. M. & Adan, R. A. Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity. Mol. Psychiatry 18, 1294\u20131301 (2013).","journal-title":"Mol. Psychiatry"},{"key":"52869_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0049-3848(02)00395-X","volume":"108","author":"D Seiffert","year":"2002","unstructured":"Seiffert, D. et al. Regulation of clot retraction by glycoprotein IIb\/IIIa antagonists. Thromb. Res. 108, 181\u2013189 (2002).","journal-title":"Thromb. Res."},{"key":"52869_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0002-9343(66)90003-9","volume":"41","author":"JP Caen","year":"1966","unstructured":"Caen, J. P. et al. Congenital bleeding disorders with long bleeding time and normal platelet count: I. Glanzmann\u2019s thrombasthenia (report of fifteen patients). Am. J. Med. 41, 4\u201326 (1966).","journal-title":"Am. J. Med."},{"key":"52869_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/44599","volume":"401","author":"DA Law","year":"1999","unstructured":"Law, D. A. et al. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature 401, 808\u2013811 (1999).","journal-title":"Nature"},{"key":"52869_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/bioo.2001.1227","volume":"29","author":"J Jiang","year":"2001","unstructured":"Jiang, J., Wang, W., Sane, D. C. & Wang, B. Synthesis of RGD analogs as potential vectors for targeted drug delivery. Bioorg. Chem. 29, 357\u2013379 (2001).","journal-title":"Bioorg. Chem."},{"key":"52869_CR54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"52869_CR55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1107\/S0021889810015608","volume":"43","author":"PV Afonine","year":"2010","unstructured":"Afonine, P. V. et al. phenix.model_vs_data: a high-level tool for the calculation of crystallographic model and data statistics. J. Appl. Crystallogr. 43, 669\u2013676 (2010).","journal-title":"J. Appl. Crystallogr."},{"key":"52869_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"52869_CR57","doi-asserted-by":"publisher","first-page":"e0188921","DOI":"10.1371\/journal.pone.0188921","volume":"12","author":"M Mussbacher","year":"2017","unstructured":"Mussbacher, M. et al. Optimized plasma preparation is essential to monitor platelet-stored molecules in humans. PLoS ONE 12, e0188921 (2017).","journal-title":"PLoS ONE"},{"key":"52869_CR58","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI109597","volume":"64","author":"JS Bennett","year":"1979","unstructured":"Bennett, J. S. & Vilaire, G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J. Clin. Investig. 64, 1393\u20131401 (1979).","journal-title":"J. Clin. Investig."},{"key":"52869_CR59","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/bab.1762","volume":"66","author":"SS Gapizov","year":"2019","unstructured":"Gapizov, S. S. et al. Fusion with an albumin-binding domain improves pharmacokinetics of an alphavbeta3-integrin binding fibronectin scaffold protein. Biotechnol. Appl. Biochem. 66, 617\u2013625 (2019).","journal-title":"Biotechnol. Appl. Biochem."},{"key":"52869_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-61779-307-3_8","volume":"788","author":"KL Tucker","year":"2012","unstructured":"Tucker, K. L., Sage, T. & Gibbins, J. M. Clot retraction. Methods Mol. Biol. 788, 101\u2013107 (2012).","journal-title":"Methods Mol. Biol."},{"key":"52869_CR61","doi-asserted-by":"publisher","unstructured":"Gollomp, K. et al. Neutrophil accumulation and NET release contribute to thrombosis in HIT. JCI Insight 3, https:\/\/doi.org\/10.1172\/jci.insight.99445 (2018).","DOI":"10.1172\/jci.insight.99445"},{"key":"52869_CR62","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.6648524","volume":"222","author":"KY Hui","year":"1983","unstructured":"Hui, K. Y., Haber, E. & Matsueda, G. R. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 222, 1129\u20131132 (1983).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52869-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52869-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52869-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T13:01:59Z","timestamp":1728046919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52869-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52869"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52869-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.11.602533","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.A. and D.W.L. are co-founders of a 2021 startup aimed at generating and testing novel integrin antagonists. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8612"}}